Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer.

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

SKRICKOVA Jana BABICKOVA Lenka KAPLANOVÁ Jana KUBOVÁ Olga PÁLKOVÁ Ivana TOMÍSKOVÁ Marcela

Year of publication 2003
Type Article in Proceedings
Conference Woorkbook of Iressa Clinical Experience Meeting
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords non-small-cell lung cancer; gefitinib treatment; antitumour activity;
Description A case is presented of a 73-year old female non-smoker with advanced, symptomatic NSCLC, initially treated with gemcitabine and carboplatin, but improved only after oral gefitinib 250mg/day, which was well tolerated and demonstrated good antitumour activity.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info